The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

Table 3

The influence of pharmacological preconditioning with sevoflurane on graft function and length of ICU and hospital stay.

	Sevoflurane group	Control group	𝑃 value
Peak AST, IU/L	792 (481–1436)	1861 (519–3590)	0,038*
Peak ALT, IU/L	606 (344–892)	1191 (392–2137)	0,117*
Incidence of EAD, %	16,7 (5 of 30)	50,0 (15 of 30)	0,013**
Length of ICU stay, d	6 (5–8)	6 (4–9)	0,655*
Length of hospital stay, d	18 (14–22)	18 (15–26)	0,833*

Data are as median (interquartile range). AST: aspartate aminotransferase, ALT: alanine aminotransferase, EAD: early allograft dysfunction, ICU: intensive care unit.
*Mann-Whitney test, **Fisher’s exact test, two tailed.